Precision pen on Lab White
ZENSLIM
Retatrutide (GLP-1 / GIP / glucagon agonist)
A triple-agonist peptide acting on the GLP-1, GIP and glucagon receptors, synthesized to a written specification and verified at the molecular level before listing. Studied for coordinated satiety, insulinotropic and energy-expenditure signalling.
Ships FREE from within Canada · No customs · no border delays.
OVERVIEW
A triple-receptor peptide studied in metabolic research.
ZENSLIM is built on Retatrutide, a triple-agonist peptide that acts on the GLP-1, GIP and glucagon receptors at once. It is studied for coordinated satiety, insulinotropic and energy-expenditure signalling — a mechanism that has placed it at the centre of recent metabolic research.
The incretin field it belongs to is one of the most heavily studied areas in modern metabolic science, which is also why it draws regulatory attention: compounds in this family form the basis of authorized prescription medicines, which ZENSLIM is not and does not replace.
ZENSLIM is a research-grade formulation, not an authorized medicine, and Zenovate makes no claim about its effects in humans. Every batch is synthesized to a written specification and tested for identity, purity and stability by an independent accredited laboratory before it is listed.
SPECIFICATIONS
THE RESEARCH
Cited research areas: incretin biology and multi-receptor (GLP-1 / GIP / glucagon) signalling; metabolic and energy-expenditure pathways; peptide stability and formulation chemistry.
We cite the literature. We make no claims about effects or outcomes, and no comparison to prescription products.
Identity · purity · stability
TESTING & QUALITY ASSURANCE
Every batch is tested before it ships.
COMPOUND FAQ
Questions specific to ZENSLIM.
Is ZENSLIM a prescription medicine?
No. ZENSLIM is a research-grade formulation with no marketing authorization in Canada; it is not a medicine and not a substitute for one.
How do I verify what is in a ZENSLIM pen?
Every batch is tested for identity, purity and stability by an independent accredited laboratory using UPLC / HPLC, LC-MS and related methods. Our full testing methodology is published on the Lab Results page.
Why does Zenovate avoid naming prescription brands?
Because comparing a research compound to an authorized medicine would be both misleading and non-compliant; they are different categories held to different standards of evidence.
Compounded products are not evaluated by Health Canada for safety, effectiveness or quality. ZENSLIM is a research-grade formulation, not a medicine, and nothing on this page is medical advice. For adults 19 and older.